THE LEGAL STATUS AND POLICY IMPLICATIONS OF PSILOCYBIN MUSHROOMS IN INDIA: A CRITICAL ANALYSIS AND REFORM PROPOSALS

Vishal, T and Gowri Shankari, R (2026) THE LEGAL STATUS AND POLICY IMPLICATIONS OF PSILOCYBIN MUSHROOMS IN INDIA: A CRITICAL ANALYSIS AND REFORM PROPOSALS. Indian Journal of Law and Legal Research, 8 (2). p. 4454. ISSN 2582-8878

[thumbnail of WhatsApp Image 2026-09-03 at 6.55.51 PM.pdf] Text
WhatsApp Image 2026-09-03 at 6.55.51 PM.pdf

Download (123kB)

Abstract

Recently, more people in various parts of India are using psilocybin mushrooms recreationally, which spotlights uncertainties in their legal status. This paper examines whether the current laws adequately cover this.
Psilocybin is indeed a scheduled substance under the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act). Still, the Act skips over
mushrooms in their natural state, thereby the principle of nullum crimen sine
lege-no crime without law, comes into force. It has led to inconsistent
policing and varying judicial outcomes, which are similar to the ambiguities
seen with other natural psychedelics, such as cannabis plants, before clearer
guidelines emerged. On top of that, the Drugs and Cosmetics Act, 1940
doesn't specifically regulate these mushrooms, leaving gaps in therapeutic
research and medical oversight. This lacks criminal control against public
health needs in India. This paper explores psilocybin's hallucinogenic
effects, its risks, such as psychological distress, and growing evidence of
benefits for mental health issues like depression, drawing from national and
global studies. This lacks criminal control against public health needs in
India. Reviewing certain decisions of the High Courts on possession,
classification as "psychotropic substances". The analysis reveals a regime
that's vague and inconsistent with the object of the NDPS Act. Finally, this
paper proposes reforms, including amendments to existing laws to address
Psilocybin mushrooms, tiered regulations (bans on recreational use and
consumption as a drug but allowances for research), and a licensing system
for clinical trials.

Item Type: Article
Subjects: Legal Studies > Health Law
Domains: Legal Studies
Depositing User: Mr IR Admin
Date Deposited: 03 Sep 2026 13:32
Last Modified: 03 Sep 2026 13:32
URI: https://ir.vistas.ac.in/id/eprint/22546

Actions (login required)

View Item
View Item